Pyridopyrimidine derivative as histamine receptor inhibitor
TW202626641APending Publication Date: 2026-07-01FAES FARMA SA
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114136096
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-20
- Filing Date
- 2025-09-19
- Publication Date
- 2026-07-01
Abstract
The invention relates to the compound of formula (I): or a salt or solvate thereof, to a pharmaceutical composition comprising the same and to its use in the treatment and / or prevention of diseases or disorders mediated by histamine H4 receptor and / or by histamine H1 receptor.
Need to check novelty before this filing date? Find Prior Art